Here's what to know about the deadly flooding, the colossal weather system that drove it in and around Kerr County, Texas, ...

Chris Long and his wife, Janet, were thrilled when he became the first patient at MUSC Health to receive the Alzheimer’s drug ...

INmune Bio’s XPro shows promise for Alzheimer's with neuroinflammation despite Phase II miss. Read here for a detailed ...

Kevin Smith, a resident of Clifton Park, is experiencing the benefits of a recently approved Alzheimer's drug, Leqembi, as he ...

Innovation in obesity treatments, Alzheimer's detection and medical-device applications is setting the stage for a number of ...

The FDA’s regular communications based on reports from its drug safety report database don’t always rattle investors’ cages.

INmune Bio said that a subset of Alzheimer's disease patients in the study showed clinical benefit from the therapy.

In the case of the amyloid drugs, Eisai Biogen's Leqembi (lecanemab) and Eli Lilly's Kisunla (donanemab) – there are also ...

By Siddhi Mahatole and Puyaan Singh (Reuters) -INmune Bio said on Monday its experimental Alzheimer's drug failed to improve ...